Opko Health Inc. (OPK) Sees Large Increase in Short Interest
Opko Health Inc. (NASDAQ:OPK) was the target of a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 71,636,808 shares, a growth of 3.6% from the September 15th total of 69,139,269 shares. Currently, 21.4% of the shares of the company are sold short. Based on an average trading volume of 3,421,364 shares, the days-to-cover ratio is presently 20.9 days.
Shares of Opko Health (NASDAQ:OPK) opened at 9.56 on Thursday. The company has a market cap of $5.26 billion, a PE ratio of 40.00 and a beta of 1.72. The firm’s 50-day moving average is $10.06 and its 200-day moving average is $10.08. Opko Health has a one year low of $7.12 and a one year high of $11.85.
Opko Health Company Profile
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/13/opko-health-inc-opk-sees-large-increase-in-short-interest.html
OPKO Health, Inc (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment primarily consists of its clinical laboratory operations.
Receive News & Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.